| NCT Number | NCT07033559 |
| Lead Sponsor | Thymia Limited
Collaborators: UCB Pharma |
| Conditions | Myasthenia Gravis Generalised |
| Enrollment | 240 participants |
| Start Date | 2026-02 |
| Primary Completion | 2026-06 (estimated) |
| Study Completion | 2026-12 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-28 |